An observational study fluid balance and patient outcomes in the randomized evaluation of normal vs. augmented level of replacement therapy trial

The RENAL Replacement Therapy Study Investigators

Research output: Contribution to journalArticleResearchpeer-review

151 Citations (Scopus)

Abstract

Objective: To examine associations between mean daily fluid balance during intensive care unit study enrollment and clinical outcomes in patients enrolled in the Randomized Evaluation of Normal vs. Augmented Level (RENAL) replacement therapy study. Design: Statistical analysis of data from multicenter, randomized, controlled trials. Setting: Thirty-five intensive care units in Australia and New Zealand. Patients: Cohort of 1453 patients enrolled in the RENAL study. Interventions: We analyzed the association between daily fluid balance on clinical outcomes using multivariable logistic regression, Cox proportional hazards, time-dependent analysis, and repeated measure analysis models. Measurements and Main Results: During intensive care unit stay, mean daily fluid balance among survivors was-234 mL/day compared with +560 mL/day among nonsurvivors (p < .0001). Mean cumulative fluid balance over the same period was-1941 vs. +1755 mL (p = .0003). A negative mean daily fluid balance during study treatment was independently associated with a decreased risk of death at 90 days (odds ratio 0.318; 95% confidence interval 0.24-0.43; p < .000.1) and with increased survival time (p < .0001). In addition, a negative mean daily fluid balance was associated with significantly increased renal replacement-free days (p = .0017), intensive care unit-free days (p < .0001), and hospital-free days (p = .01). These findings were unaltered after the application of different statistical models. Conclusions: In the RENAL study, a negative mean daily fluid balance was consistently associated with improved clinical outcomes. Fluid balance may be a target for specific manipulation in future interventional trials of critically ill patients receiving renal replacement therapy.

Original languageEnglish
Pages (from-to)1753-1760
Number of pages8
JournalCritical Care Medicine
Volume40
Issue number6
DOIs
Publication statusPublished - 1 Jan 2012
Externally publishedYes

Keywords

  • acute kidney injury
  • continuous renal replacement therapy
  • hemodialysis
  • hemofiltration
  • intensive care
  • kidney

Cite this

@article{b25ce7a8175349efaef9b11fac41b334,
title = "An observational study fluid balance and patient outcomes in the randomized evaluation of normal vs. augmented level of replacement therapy trial",
abstract = "Objective: To examine associations between mean daily fluid balance during intensive care unit study enrollment and clinical outcomes in patients enrolled in the Randomized Evaluation of Normal vs. Augmented Level (RENAL) replacement therapy study. Design: Statistical analysis of data from multicenter, randomized, controlled trials. Setting: Thirty-five intensive care units in Australia and New Zealand. Patients: Cohort of 1453 patients enrolled in the RENAL study. Interventions: We analyzed the association between daily fluid balance on clinical outcomes using multivariable logistic regression, Cox proportional hazards, time-dependent analysis, and repeated measure analysis models. Measurements and Main Results: During intensive care unit stay, mean daily fluid balance among survivors was-234 mL/day compared with +560 mL/day among nonsurvivors (p < .0001). Mean cumulative fluid balance over the same period was-1941 vs. +1755 mL (p = .0003). A negative mean daily fluid balance during study treatment was independently associated with a decreased risk of death at 90 days (odds ratio 0.318; 95{\%} confidence interval 0.24-0.43; p < .000.1) and with increased survival time (p < .0001). In addition, a negative mean daily fluid balance was associated with significantly increased renal replacement-free days (p = .0017), intensive care unit-free days (p < .0001), and hospital-free days (p = .01). These findings were unaltered after the application of different statistical models. Conclusions: In the RENAL study, a negative mean daily fluid balance was consistently associated with improved clinical outcomes. Fluid balance may be a target for specific manipulation in future interventional trials of critically ill patients receiving renal replacement therapy.",
keywords = "acute kidney injury, continuous renal replacement therapy, hemodialysis, hemofiltration, intensive care, kidney",
author = "{Correction Bellomo}, Rinaldo and Alan Cass and Louise Cole and Simon Finfer and Martin Gallagher and Joanne Lee and Lo, {Serigne N.} and Colin McArthur and Shay McGuinness and John Myburgh and Robyn Norton and Carlos Scheinkestel and {The RENAL Replacement Therapy Study Investigators}",
year = "2012",
month = "1",
day = "1",
doi = "10.1097/CCM.0b013e318246b9c6",
language = "English",
volume = "40",
pages = "1753--1760",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams & Wilkins",
number = "6",

}

An observational study fluid balance and patient outcomes in the randomized evaluation of normal vs. augmented level of replacement therapy trial. / The RENAL Replacement Therapy Study Investigators.

In: Critical Care Medicine, Vol. 40, No. 6, 01.01.2012, p. 1753-1760.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - An observational study fluid balance and patient outcomes in the randomized evaluation of normal vs. augmented level of replacement therapy trial

AU - Correction Bellomo, Rinaldo

AU - Cass, Alan

AU - Cole, Louise

AU - Finfer, Simon

AU - Gallagher, Martin

AU - Lee, Joanne

AU - Lo, Serigne N.

AU - McArthur, Colin

AU - McGuinness, Shay

AU - Myburgh, John

AU - Norton, Robyn

AU - Scheinkestel, Carlos

AU - The RENAL Replacement Therapy Study Investigators

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Objective: To examine associations between mean daily fluid balance during intensive care unit study enrollment and clinical outcomes in patients enrolled in the Randomized Evaluation of Normal vs. Augmented Level (RENAL) replacement therapy study. Design: Statistical analysis of data from multicenter, randomized, controlled trials. Setting: Thirty-five intensive care units in Australia and New Zealand. Patients: Cohort of 1453 patients enrolled in the RENAL study. Interventions: We analyzed the association between daily fluid balance on clinical outcomes using multivariable logistic regression, Cox proportional hazards, time-dependent analysis, and repeated measure analysis models. Measurements and Main Results: During intensive care unit stay, mean daily fluid balance among survivors was-234 mL/day compared with +560 mL/day among nonsurvivors (p < .0001). Mean cumulative fluid balance over the same period was-1941 vs. +1755 mL (p = .0003). A negative mean daily fluid balance during study treatment was independently associated with a decreased risk of death at 90 days (odds ratio 0.318; 95% confidence interval 0.24-0.43; p < .000.1) and with increased survival time (p < .0001). In addition, a negative mean daily fluid balance was associated with significantly increased renal replacement-free days (p = .0017), intensive care unit-free days (p < .0001), and hospital-free days (p = .01). These findings were unaltered after the application of different statistical models. Conclusions: In the RENAL study, a negative mean daily fluid balance was consistently associated with improved clinical outcomes. Fluid balance may be a target for specific manipulation in future interventional trials of critically ill patients receiving renal replacement therapy.

AB - Objective: To examine associations between mean daily fluid balance during intensive care unit study enrollment and clinical outcomes in patients enrolled in the Randomized Evaluation of Normal vs. Augmented Level (RENAL) replacement therapy study. Design: Statistical analysis of data from multicenter, randomized, controlled trials. Setting: Thirty-five intensive care units in Australia and New Zealand. Patients: Cohort of 1453 patients enrolled in the RENAL study. Interventions: We analyzed the association between daily fluid balance on clinical outcomes using multivariable logistic regression, Cox proportional hazards, time-dependent analysis, and repeated measure analysis models. Measurements and Main Results: During intensive care unit stay, mean daily fluid balance among survivors was-234 mL/day compared with +560 mL/day among nonsurvivors (p < .0001). Mean cumulative fluid balance over the same period was-1941 vs. +1755 mL (p = .0003). A negative mean daily fluid balance during study treatment was independently associated with a decreased risk of death at 90 days (odds ratio 0.318; 95% confidence interval 0.24-0.43; p < .000.1) and with increased survival time (p < .0001). In addition, a negative mean daily fluid balance was associated with significantly increased renal replacement-free days (p = .0017), intensive care unit-free days (p < .0001), and hospital-free days (p = .01). These findings were unaltered after the application of different statistical models. Conclusions: In the RENAL study, a negative mean daily fluid balance was consistently associated with improved clinical outcomes. Fluid balance may be a target for specific manipulation in future interventional trials of critically ill patients receiving renal replacement therapy.

KW - acute kidney injury

KW - continuous renal replacement therapy

KW - hemodialysis

KW - hemofiltration

KW - intensive care

KW - kidney

UR - http://www.scopus.com/inward/record.url?scp=84861494538&partnerID=8YFLogxK

U2 - 10.1097/CCM.0b013e318246b9c6

DO - 10.1097/CCM.0b013e318246b9c6

M3 - Article

VL - 40

SP - 1753

EP - 1760

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 6

ER -